Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)

新发、再发和人畜共患疾病与多样性前沿 (FrERZD2)

基本信息

  • 批准号:
    10313230
  • 负责人:
  • 金额:
    $ 35.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Our nation is nearly paralyzed by the twin pandemics of COVID-19 and painful inequities in health outcomes among COVID-19 infected Americans of differing ethnicities. To help address these, we seek sponsorship to train the next generation of pandemic and emerging disease researchers in the FRONTIERS IN EMERGING, RE-EMERGING AND ZOONOTIC DISEASES AND DIVERSITY. FrERZD2 will launch and sustain three vital undertakings: sophisticated courses for skills development; relevant vital research experiences; and career mentoring activities. Responsive to PAR-20-289, it is designed for 16 trainees who are graduate and medical students, medical residents, postdoctoral fellows, and/or early-career faculty, and who also are US citizens or permanent residents. The week-long course will help to ensure that clinically active scientists (especially physicians) are able to obtain permission to participate. Too few laboratories are led by under-represented minority (URM) scientists, and not enough new URM trainees graduate. We seek 5 years of sponsorship to offer FrERZD2 courses at Morehouse School of Medicine (MSM), an HBCU, in 2021, 2023, and 2025 and Ponce Health Sciences University (PHSU), a Hispanic-Serving Institution, in 2022 and 2024. Under the overall directorship of Gerald Schatten from Pittsburgh, along with Jonathan Stiles at MSM, Idhaliz Flores from PHSU, and Calvin Simerly, also from Pittsburgh, FrERZD2 is overseen by an external scientific advisory committee. It offers dynamic advanced training courses consisting of daily lectures on emerging concepts, followed by extended discussion, laboratory research, technologically intense workshops, and informal seminars. Our similar training programs have recruited participants of whom 34% self-identify as African American/Black and 30% as Hispanic Americans; 66% are women, and 62% are from URM institutions. Six specific aims are proposed. Aim 1. Provide conceptual education and experimental training. Aim 2. Provide background information and self-reflective exercises and demonstrations to understand, appreciate, and address the historic and current underpinnings of inequities in the research workforce’s diversity and disparities in health care. Aim 3. Sponsor meaningful mentored research. Aim 4. Discuss career planning. Aim 5. Educate participants on the responsible conduct of research. Aim 6. Provide unbiased, quantitative, independent mechanisms to track trainees’ careers, comprehensively and longitudinally. The program’s name, FRONTIERS IN EMERGING, RE-EMERGING AND ZOONOTIC DISEASES AND DIVERSITY, acknowledges our hope that the COVID pandemic may soon recede significantly and our realization that other emerging, reemerging, and zoonotic diseases will arise that must be timely addressed. Overall, in conducting this program, we will continue to enhance and expand the research careers of the most promising scientists, with sensitivity to ensuring full diversity in the NIAID workforce.
项目摘要 我们的国家几乎因COVID-19的双重流行和健康结果的痛苦不平等而瘫痪 在不同种族的COVID-19感染的美国人中。为了帮助解决这些问题,我们寻求赞助, 培养下一代流行病和新兴疾病研究人员, 复活和动物传染病和多样性。FrERZD 2将发射和维持三个重要的 事业:复杂的技能发展课程;相关的重要研究经验;和职业 辅导活动。响应PAR-20-289,它是专为16名学员谁是研究生和医学 学生,医学居民,博士后研究员和/或早期职业教师,并且也是美国公民或 永久居民。为期一周的课程将有助于确保临床活跃的科学家(特别是 医生)能够获得参与许可。太少的实验室由代表性不足的人领导 少数民族(URM)科学家,没有足够的新URM学员毕业。我们寻求5年的赞助, 在2021年,2023年和2025年在HBCU的Morehouse医学院(MSM)提供FrERZD 2课程, 庞塞健康科学大学(PHSU),西班牙裔服务机构,在2022年和2024年。下 杰拉尔德Schatten从匹兹堡,沿着乔纳森斯泰尔斯在男男性接触,Idhaliz弗洛雷斯从 PHSU和同样来自匹兹堡的卡尔文西默利,FrERZD 2由外部科学顾问监督 以马克思它提供动态的高级培训课程,包括关于新兴概念的每日讲座, 随后是广泛的讨论,实验室研究,技术密集的研讨会,和非正式的 研讨会等我们的类似培训项目招募了34%的参与者, 美国人/黑人,30%为西班牙裔美国人; 66%为女性,62%来自URM机构。六 提出了具体目标。目标1.提供概念教育和实验培训。目标二。提供 背景信息和自我反思练习和示范,以理解,欣赏, 解决研究人员多样性和差异方面的历史和当前不平等基础 在医疗保健方面。目标3。赞助有意义的指导研究。目标4。讨论职业规划。目标5。 教育参与者如何负责任地开展研究。目标6。提供公正的,定量的, 建立独立机制,全面和纵向跟踪学员的职业发展。程序的名字, 新出现、重新出现和动物传染病与多样性前沿, 我们希望COVID大流行很快会显著消退,我们意识到其他新兴的, 重新出现,动物传染病也会出现,必须及时加以解决。总的来说,在进行这项工作时, 计划,我们将继续加强和扩大最有前途的科学家的研究事业, 确保NIAID劳动力的充分多样性的敏感性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GERALD SCHATTEN其他文献

GERALD SCHATTEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GERALD SCHATTEN', 18)}}的其他基金

Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
  • 批准号:
    10460942
  • 财政年份:
    2021
  • 资助金额:
    $ 35.3万
  • 项目类别:
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
  • 批准号:
    10172529
  • 财政年份:
    2021
  • 资助金额:
    $ 35.3万
  • 项目类别:
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)
新发、再发和人畜共患疾病与多样性前沿 (FrERZD2)
  • 批准号:
    10666744
  • 财政年份:
    2021
  • 资助金额:
    $ 35.3万
  • 项目类别:
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)
通过本科教育促进美国原住民老龄化研究的多样性(美国原住民 ADAR)
  • 批准号:
    10619000
  • 财政年份:
    2021
  • 资助金额:
    $ 35.3万
  • 项目类别:
Forefronts in Substance Abuse Disorders during Pregnancy, Postpartum, and Pediatrics (FrSADP3)
妊娠期、产后和儿科药物滥用疾病的前沿 (FrSADP3)
  • 批准号:
    10741269
  • 财政年份:
    2018
  • 资助金额:
    $ 35.3万
  • 项目类别:
Frontiers in Addiction Research and Pregnancy
成瘾研究和怀孕的前沿
  • 批准号:
    10113573
  • 财政年份:
    2018
  • 资助金额:
    $ 35.3万
  • 项目类别:
Frontiers in Addiction Research and Pregnancy
成瘾研究和怀孕的前沿
  • 批准号:
    9532481
  • 财政年份:
    2018
  • 资助金额:
    $ 35.3万
  • 项目类别:
Frontiers in Addiction Research and Pregnancy
成瘾研究和怀孕的前沿
  • 批准号:
    10359163
  • 财政年份:
    2018
  • 资助金额:
    $ 35.3万
  • 项目类别:
Frontiers in Alzheimer's and Aging Research (FrA2R)
阿尔茨海默病和衰老研究前沿 (FrA2R)
  • 批准号:
    10441312
  • 财政年份:
    2012
  • 资助金额:
    $ 35.3万
  • 项目类别:
Rehabilitative and Regenerative Medicine for Minority Health & Health Disparities
少数民族健康的康复和再生医学
  • 批准号:
    8542883
  • 财政年份:
    2012
  • 资助金额:
    $ 35.3万
  • 项目类别:

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 35.3万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 35.3万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 35.3万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 35.3万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 35.3万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 35.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了